Information about Tavira Therapeutics
My details
*
*
*

Tavira Therapeutics (SRL)

BE 0802.591.262

Gaston Geenslaan 3, 3001 Leuven

Company information

Status
Active

Enterprise number

BE0802.591.262

VAT liability
Yes
Established
09-06-2023
Last balance sheet year
2024
Company size
Small 1 FTE
Principal activity
Research and development in other physical and natural sciences
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Tavira Therapeutics

2024
Profit/Loss € -920,680
Equity € 245,138
Gross margin € -122,148
Employees 1

Publications from Tavira Therapeutics

Date Publication
05-11-2025 Capital - Shares (NL)
25-04-2025 Resignations - Appointments (NL)
25-11-2024 Registered Office (NL)
11-04-2024 Modification(s) Articles of Association (NL)
20-06-2023 Capital - Shares - Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Tavira Therapeutics?
The VAT number of Tavira Therapeutics is BE 0802.591.262.
Wat is the PEPPOL ID of Tavira Therapeutics?
The PEPPOL ID of Tavira Therapeutics is 0208:0802591262. Log in or start a free trial to see the full overview.
When was Tavira Therapeutics founded?
Tavira Therapeutics was founded on 09-06-2023.
What is the address of Tavira Therapeutics?
The current registered office of Tavira Therapeutics is located at Gaston Geenslaan 3, 3001 Leuven.
When was the last time Tavira Therapeutics filed their annual financial statements?
The most recent financial statements of Tavira Therapeutics were filed on 18-07-2025.
How many employees does Tavira Therapeutics have?
There are 1 FTEs working at Tavira Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Tavira Therapeutics?
At the time of its most recent financial statements, Tavira Therapeutics did not publish any turnover figures. Tavira Therapeutics reported a gross margin of -€122,148.42.

Sources